Xylem (NYSE:XYL – Free Report) had its target price cut by JPMorgan Chase & Co. from $137.00 to $118.00 in a report released on Monday,Benzinga reports. They currently have a neutral rating on the industrial products company’s stock.
Several other equities research analysts have also issued reports on XYL. Barclays dropped their price target on Xylem from $159.00 to $139.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 13th. Robert W. Baird raised their price objective on Xylem from $163.00 to $165.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 29th. Oppenheimer reaffirmed an “outperform” rating and issued a $150.00 price objective (down from $158.00) on shares of Xylem in a report on Wednesday, October 14th. Stifel Nicolaus set a $141.00 target price on shares of Xylem in a research note on Monday. Finally, UBS Group dropped their target price on shares of Xylem from $138.00 to $112.00 and set a “neutral” rating on the stock in a report on Monday, October 5th. Eight analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $140.85.
Check Out Our Latest Research Report on Xylem
Xylem Trading Up 1.2%
Shares of NYSE XYL opened at $106.32 on Monday. The stock’s 50 day moving average price is $107.38 and its two-hundred day moving average price is $113.54. Xylem has a 52-week low of $98.58 and a 52-week high of $154.27. The stock has a market capitalization of $24.82 billion, a P/E ratio of 25.31, a PEG ratio of 1.69 and a beta of 1.00. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23.
Xylem (NYSE:XYL – Get Free Report) last released its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. The company had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%. Xylem’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, analysts anticipate that Xylem will post 5.65 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. Xylem’s dividend payout ratio is 40.95%.
Institutional Trading of Xylem
Institutional investors and hedge funds have recently made changes to their positions in the stock. XXEC Inc. acquired a new position in Xylem during the 2nd quarter valued at approximately $850,841,000. BlackRock Inc. acquired a new stake in Xylem in the second quarter worth $2,959,730,000. Bank of New York Mellon Corp acquired a new stake in Xylem in the second quarter worth $552,313,000. Hsbc Holdings PLC acquired a new stake in Xylem in the second quarter worth $319,785,000. Finally, Deutsche Bank AG bought a new stake in Xylem in the second quarter valued at $223,165,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.
The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.
Further Reading
- Five stocks we like better than Xylem
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
